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Background: Interstitial deletions affecting the proximal long arm of chromosome 3 have been rarely reported
in the literature. The deleted segments vary in localization and size with different breakpoints making
genotype-phenotype correlation very difficult. Until now, a girl with a 1.9-Mb interstitial deletion of
3q13.2q13.31 and 14 novel patients with deletions in 3q11q23 have been reported.
Results: Here we report on a 7-year-old girl with neuropsychiatric disorders and renal, vascular and skeletal anomalies.
Array-CGH analysis revealed a small rare inherited 3q13.31 deletion containing only two genes, GAP43 and LSAMP.
The mutation analysis of the two genes was negative on the other non-deleted chromosome. GAP43 is considered a
crucial component for an effective regenerative response in the nervous system and its mRNA is localized exclusively
to nerve tissue where the protein is linked to the synaptosomal membrane. LSAMP is a 64- to 68-kD neuronal surface
glycoprotein found in cortical and subcortical regions of the limbic system that acts as an adhesion molecule and
guides the development of specific patterns of neuronal connection. The deleted region is adjacent to a “desert gene”
region extending 2.099 Mb.
Conclusions: We discuss the effects of GAP43 and LSAMP haploinsufficiency, proposing that their deletion may be
responsible for the main phenotype. Further cases with similar microdeletion are expected to be diagnosed and will
help to better characterize the clinical spectrum of phenotypes associated with 3q13.31 microdeletion.
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Interstitial deletions of the proximal long arm of chromo-
some 3 are quite rare. In addition, the deleted segments
vary in localization and size and have different breakpoints,
making genotype-phenotype correlation very difficult.
A girl with a 1.9-Mb interstitial deletion of 3q13.2q13.31
presenting with dysmorphic features, muscle hypotonia,
and developmental delay was reported [1]. More recently,
14 novel patients with deletions in 3q11q23 were investi-
gated and compared with 13 previously reported patients
[2]. The reported deleted segments were very different in
length, spanning from 580 Kb to 22.4 Mb and covering
the region 3q12.3q21.3. The same authors indicate, among
others, GAP43 and LSAMP as strong candidate genes
for developmental delay. GAP43 is involved in neurite* Correspondence: eli.tassano@gmail.com
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reproduction in any medium, provided the oroutgrowth, neurotransmission, and synaptic plasticity. It
has been recently identified as a candidate gene for autism
and autistic-like manifestations in humans and mice [3-5].
LSAMP gene gives rise to LAMP, which is a 64- to 68-
kDa heavily glycosylated protein, structurally characte-
rized by three immunoglobulin (Ig) domains [6]. LAMP
protein proved to be specific to the cortical and sub-
cortical limbic-associated regions, but it has been found
less intensely in the midbrain and hindbrain of the de-
veloping and adult brain [7]. Studies in both humans
and mice have demonstrated the involvement of LSAMP
in neuropsychiatric features and behaviour [8-11].
Here, using array-CGHanalysis, we have identified a
small rare inherited 3q13.31 deletion containing only
two genes (GAP43 and LSAMP) in a girl with neuro-
psychiatric disorders associated to renal, vascular, and
skeletal anomalies.Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Gimelli et al. Molecular Cytogenetics 2013, 6:52 Page 2 of 5
http://www.molecularcytogenetics.org/content/6/1/52Case presentation
A 7-year-old girl (Figure 1) was referred to our hospital
because of developmental delay and clumsiness. Her
father had slightly delayed psychomotor development
but his cognitive level was never tested. The patient was
born at term to unrelated healthy parents after an un-
eventful pregnancy. At birth, weight and length were
normal, 3580 g and 47 cm, respectively. Postnatal over-
growth was evident: weight was 38 kg (90th-97th cen-
tile), and height 130 cm (75th-90th centile). Distinctive
facial features like tented upper lip and arched palate
were present, too. Although no delay in reaching psy-
chomotor development milestones was reported, she
presented behavioural immaturity, clumsiness, motor in-
coordination, and attention deficit. Moreover, muscular
examination showed hypotonia. Jumping and deambula-
tion were clumsy, in particular walking on heels and on
tiptoes. Electroencephalography revealed paroxysm in
the temporal region, with no seizure-related pattern nor
history of seizures. Abdominal ultrasonography revealed
a small left kidney, with puckered appearance, while the
right kidney was increased in size to compensate for the
malformation. Renal scintigraphy showed 4% residual
function. The abdominal ultrasonography also showed
dilated left epigastric vein, evident on abdominal wall.
Subsequent magnetic resonance angiography revealed
inferior vena cava agenesis. Common iliac veins were ab-
sent, too. Collateral venous circulation was identified viaFigure 1 The patient.ectasic paravertebral veins and azygos-hemiazygos vein
system. Furthermore, hypoplasia of left external iliac,
popliteal and femoral veins was showed. The left renal
artery coul not be visualized. Finally, the patient pre-
sented skeletal malformations, in particular: left leg
longer than right leg, flat feet, hypoplastic right lower
limb, and femoral varus deformity.
Conventional cytogenetic analysis of the proposita and
her parents showed a normal karyotype. In the absence
of an etiological diagnosis an array-CGH analysis using
Human Genome CGH Microarray Kit G3 180 (Agilent
Technologies, Palo Alto, USA) with ~13 Kb overall median
probe spacing, was performed. Array-CGH analysis identi-
fied a 1.362 Mb deletion at 3q13.31 band with breakpoints
at genomic positions 115,157,887 bp and 116,520,120 bp
(GRCh37/hg19, Feb 2009) (Figure 2A, B). The deleted
region is adjacent to a “desert gene” region extending
2.099 Mb (chr3:116,520,120-118,619,479) (Figure 2C).
The deletion was inherited from the father and contains
only two genes, GAP43 (MIM 162060) and LSAMP (MIM
603241), and a long non-coding RNA (LSAMP-AS3)
(Figure 2C). The region is not covered by benign CNVs
(http://dgv.tcag.ca/dgv/app/home). Mutational screening
of GAP43 and LSAMP performed by bi-directional
Sanger sequencing of exons and flanking introns, was
negative on the homologous allele.
Recently, Molin et al. [2] reported on 14 patients with
a novel microdeletion syndrome at 3q13.31 characte-
rized by developmental delay, postnatal overgrowth, hy-
poplastic male genitals, and facial dysmorphisms. The
deleted region spanned from 580 Kb to 22.4 Mb with
different boundaries. Among them only one patient (pa-
tient 14) carried a deletion of 1.176 Mb with an uncer-
tain inheritance (absent in the mother and father not
tested) similar to our case. This deletion involved
GAP43 and LSAMP genes but unfortunately a not better
specified “developmental delay” was the only reported
phenotypic feature concerning the patient. A second
overlapping case is described in DECIPHER database
(Patient 249100), as affected by behavioural problems,
constipation, mental retardation/developmental delay,
and microcephaly.
GAP43 is found in growth cones of extending axons in
the central nervous system [12,13]. It has many functions
including growth cone navigation, neurite outgrowth,
stabilization of axonal branches, neurotransmission, and
synaptic plasticity [4]. Mice lacking one allele for GAP43
show multiple failures to establish or maintain long-
distance cortical connections. GAP43 was also recently
identified as a candidate gene for autism and autistic-like
manifestations in humans and mice [3-5] and Gap43+/−
heterozygous mice displayed decreased corpus callo-
sum and hippocampal commissure volume [5], as also
highlighted by Molin et al. [2].
Figure 2 Results of Array-CGH analysis. A) Ideogram and B) Ratio plot of array-CGH analysis show the presence of 1.362 Mb deletion at
3q13.31 band with breakpoints at genomic positions 115,157,887 bp and 116,520,120 bp (GRCh37/hg19, Feb 2009). C) Extract from the UCSC
genome browser (http://genome.ucsc.edu/) GRCh37/hg19 shows the deleted region and its gene content compared to the deletions identified
by Molin et al. [2] and by DECIPHER database.
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brane protein, and studies in both humans and mice
have demonstrated the involvement of LSAMP in neuro-
psychiatric features and behaviour [8,9].
In addition to a neuropsychiatric phenotype, our pa-
tient presented renal, vascular, and skeletal anomalies.
Interestingly, LSAMP is also expressed in kidney [14], in
cardiovascular tissues in humans [15] and in mice (MGI
database), and in osteoblasts [16,17]. Moreover, GAP43is also expressed in mouse renal-urinary system (MGI
database) and in skeletal muscles [18].
Several aspects may account for the phenotypic vari-
ability described among carriers of microdeletions/
microduplications, including variation in genetic back-
ground, epigenetic phenomena such as imprinting, ex-
pression or regulatory variation among genes in the
rearrangement region, and (in the case of deletions) the
unmasking of recessive variants residing on the single
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ence of mutations in the homologous alleles of LSAMP
and GAP43 genes. However, we cannot exclude the pos-
sibility of a variable expressivity or an incomplete pene-
trance, since the father of our patient showed a mild
neurological phenotype.
Conclusions
In conclusion, we have identified a patient with a dele-
tion in 3q13.31 chromosome band containing only two
genes (LSAMP and GAP43) inherited from his father.
No mutation was present on the homologous alleles.
The father had slightly delayed psychomotor develop-
ment. We suggest that LSAMP and GAP43 genes are the
most likely candidate genes for the phenotypic core of
our patient. Nevertheless, the description of more pa-
tients with similar microdeletions would be useful to
further delineate the main clinical features and to
understand the function of the genes contained in the
deleted chromosomal interval.
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of the members of the family treated at the Istituto
Giannina Gaslini, Genova, Italy. The parents of the pa-
tient gave written informed consent allowing molecular
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